Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dare Bioscience (DARE) Current Leases (2020 - 2025)

Dare Bioscience (DARE) has disclosed Current Leases for 6 consecutive years, with $609224.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Current Leases rose 20.44% year-over-year to $609224.0, compared with a TTM value of $609224.0 through Sep 2025, up 20.44%, and an annual FY2024 reading of $548638.0, up 17.05% over the prior year.
  • Current Leases was $609224.0 for Q3 2025 at Dare Bioscience, up from $588478.0 in the prior quarter.
  • Across five years, Current Leases topped out at $609224.0 in Q3 2025 and bottomed at $195000.0 in Q3 2023.
  • Average Current Leases over 5 years is $418794.0, with a median of $418946.0 recorded in 2021.
  • The sharpest move saw Current Leases plummeted 49.74% in 2023, then soared 159.4% in 2024.
  • Year by year, Current Leases stood at $270546.0 in 2021, then surged by 47.25% to $398391.0 in 2022, then rose by 17.65% to $468726.0 in 2023, then grew by 17.05% to $548638.0 in 2024, then rose by 11.04% to $609224.0 in 2025.
  • Business Quant data shows Current Leases for DARE at $609224.0 in Q3 2025, $588478.0 in Q2 2025, and $568297.0 in Q1 2025.